Helius Medical Net Income Over Time
| HSDT Stock | USD 2.21 0.28 14.51% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Helius Medical Performance and Helius Medical Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will Helius introduce new products? Factors like these will boost the valuation of Helius Medical. Market participants price Helius higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (829.83) | Revenue Per Share | Quarterly Revenue Growth 12.667 | Return On Assets | Return On Equity |
Understanding Helius Medical Techn requires distinguishing between market price and book value, where the latter reflects Helius's accounting equity. The concept of intrinsic value - what Helius Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Helius Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Helius Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income Analysis
Compare Helius Medical Techn and related stocks such as Nano X Imaging, Inogen Inc, and Electromed Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NNOX | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (22.6 M) | (43.5 M) | (61.8 M) | (105.2 M) | (60.8 M) | (53.5 M) | (48.2 M) | (50.6 M) |
| INGN | (2 M) | (2 M) | 564 K | 25.4 M | 6.8 M | 11.6 M | 20.5 M | 21 M | 51.8 M | 20.9 M | (5.8 M) | (6.3 M) | (83.8 M) | (102.4 M) | (35.9 M) | (32.3 M) | (30.7 M) |
| ELMD | 267.9 K | 186.6 K | (1.3 M) | (1.3 M) | 1.1 M | 2.2 M | 2.2 M | 1.8 M | 2 M | 4.2 M | 2.4 M | 2.3 M | 3.2 M | 5.2 M | 7.5 M | 8.7 M | 9.1 M |
| CATX | (437.6 K) | (2.8 M) | (3.5 M) | (3.9 M) | (6 M) | (3.7 M) | (4.7 M) | (6.2 M) | (4.8 M) | (3.3 M) | (3.2 M) | (7.3 M) | (14.7 M) | (46.5 M) | (79.3 M) | (71.4 M) | (67.8 M) |
| OM | (49.8 M) | (49.8 M) | (49.8 M) | (49.8 M) | (49.8 M) | (49.8 M) | (49.8 M) | (49.8 M) | (49.8 M) | (68.3 M) | (120.7 M) | (131.9 M) | (163 M) | (172.8 M) | (128 M) | (81.7 M) | (85.7 M) |
| PROF | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (11.8 M) | (12.1 M) | (15 M) | (15.2 M) | (15.2 M) | (21.6 M) | (30.7 M) | (28.7 M) | (28.6 M) | (26.5 M) | (23.8 M) | (25 M) |
| TLSI | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (47.2 M) | (59.4 M) | (33.2 M) | (29.9 M) | (31.4 M) |
| QTRX | (15.9 M) | (15.9 M) | (15.9 M) | (15.9 M) | (15.9 M) | (15.9 M) | (23.2 M) | (27 M) | (31 M) | (40.8 M) | (31.5 M) | (57.7 M) | (99.6 M) | (28.4 M) | (38.5 M) | (34.7 M) | (36.4 M) |
| INFU | (24.8 K) | (45.4 M) | (1.5 M) | 1.7 M | 3.4 M | 3.7 M | (222 K) | (20.7 M) | (1.1 M) | 1.4 M | 17.3 M | 1.4 M | 18 K | 872 K | 2.3 M | 2.7 M | 2.8 M |
Helius Medical Techn and related stocks such as Nano X Imaging, Inogen Inc, and Electromed Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Helius Medical Techn financial statement analysis. It represents the amount of money remaining after all of Helius Medical Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Helius Medical Technologies | HSDT |
Specialization | Financial Services, Health Care Equipment & Services |
| Business Address | 642 Newtown Yardley |
| Exchange | NASDAQ Exchange |
USD 2.21
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.